口咽癌治疗后监测的降级
回顾2014年赫尔辛基大学医院耳鼻咽喉科366次口咽鳞状细胞癌随访,26次(7%)因新症状就诊并检出4例复发,340次(93%)无新症状就诊未检出复发;新症状与复发显著相关(P<0.001)。结论认为可减少常规随访次数,随访应侧重症状导向检查。
要点
- 366次随访中26次(7%)有新症状,检出4例复发。
- 340次(93%)无新症状随访未检出任何复发。
- 新症状与复发显著相关(P<0.001),作者认为可减少常规随访。
核心结论
- 基于本研究和既往评估口咽鳞状细胞癌预后与复发模式的研究,作者认为可减少治疗后常规随访次数,随访应侧重症状导向检查。
研究设计与样本
- 回顾性分析2014年赫尔辛基大学医院耳鼻咽喉科所有口咽鳞状细胞癌随访就诊记录,共366次。
主要发现
- 366次随访中26次(7%)为新症状就诊,检出4例复发。
- 366次随访中340次(93%)无新症状就诊,未检出任何复发。
- 新症状与复发显著相关(P<0.001)。
临床怎么用
- 作者认为可减少治疗后常规随访次数,随访应侧重症状导向检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The majority of new oropharyngeal squamous cell carcinoma (OPSCC) cases are associated with human papillomavirus and favorable prognosis. Post-treatment follow-up should be targeted to patients at greatest risk for disease recurrence. METHODS: To assess the benefits of routine clinical surveillance in OPSCC, we reviewed all follow-up visits conducted in 2014 at Helsinki University Hospital Department of Otorhinolaryngology. RESULTS: Of 366 visits, 26 (7%) were from patients presenting with a new symptom, and disease recurrence was detected in four. The presence of a new symptom was significantly associated with disease recurrence (P < 0.001). Of 366 visits, 340 (93%) were from patients presenting without new symptoms, and not a single recurrence was found during these visits. CONCLUSIONS: Based on our findings, and previous studies assessing the prognosis and pattern of recurrent OPSCC, we concluded that the number of routine post-treatment visits can be reduced. Follow-up should rather focus on symptom-directed examinations.
引用
- Ilmarinen T, Keski-Säntti H, Markkanen-Leppänen M, et al. De-escalation of post-treatment surveillance in oropharyngeal cancer. Head Neck. 2018. PMID: 30582249. doi:10.1002/hed.25593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。